Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
Jurczak W, Elmusharaf N, Fox CP, Townsend W, Paulovich AG, Whiteaker JR, Krantz F, Wun CC, Parr G, Sharma S, Munugalavadla V, Manwani R, Dean E, Munir T. Jurczak W, et al. Among authors: manwani r. Ther Adv Hematol. 2023 May 30;14:20406207231173489. doi: 10.1177/20406207231173489. eCollection 2023. Ther Adv Hematol. 2023. PMID: 37273420 Free PMC article.
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis.
Cohen OC, Sathyanath A, Petrie A, Ravichandran S, Law S, Manwani R, Foard D, Sachchithanantham S, Mahmood S, Martinez-Naharro A, Fontana M, Whelan CJ, Hawkins PN, Lachmann HJ, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: manwani r. Heart. 2022 Sep 26;108(20):1616-1622. doi: 10.1136/heartjnl-2021-320703. Heart. 2022. PMID: 35764371
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Cohen OC, Ismael A, Pawarova B, Manwani R, Ravichandran S, Law S, Foard D, Petrie A, Ward S, Douglas B, Martinez-Naharro A, Chacko L, Quarta CC, Mahmood S, Sachchithanantham S, Lachmann HJ, Hawkins PN, Gillmore JD, Fontana M, Falk RH, Whelan CJ, Wechalekar AD. Cohen OC, et al. Among authors: manwani r. Eur Heart J. 2022 Jan 31;43(4):333-341. doi: 10.1093/eurheartj/ehab507. Eur Heart J. 2022. PMID: 34472567
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC, Zheng J, Hutt D, Grigore SF, Manwani R, Sachchithanantham S, Mahmood SA, Whelan CJ, Fontana M, Martinez-Naharro A, Chacko L, Lachmann HJ, Gillmore JD, Rapezzi C, Hawkins PN, Wechalekar AD. Quarta CC, et al. Among authors: manwani r. Eur Heart J Cardiovasc Imaging. 2021 Oct 19;22(11):1304-1311. doi: 10.1093/ehjci/jeab095. Eur Heart J Cardiovasc Imaging. 2021. PMID: 34254119 Free PMC article.
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Sharpley FA, Manwani R, Petrie A, Mahmood S, Sachchithanantham S, Lachmann HJ, Martinez De Azcona Naharro A, Gillmore JD, Whelan CJ, Fontana M, Cohen O, Hawkins PN, Wechalekar AD. Sharpley FA, et al. Among authors: manwani r. Eur J Haematol. 2021 Apr;106(4):537-545. doi: 10.1111/ejh.13582. Epub 2021 Jan 27. Eur J Haematol. 2021. PMID: 33460466
Amyloidosis Diagnosed in Solid Organ Transplant Recipients.
Sharpley FA, Fontana M, Gilbertson JA, Gillmore JD, Hawkins PN, Mahmood S, Manwani R, Martinez-Naharro A, Quarta C, Rezk TM, Rowczenio D, Sachchithanantham S, Whelan CJ, Wechalekar AD, Lachmann HJ. Sharpley FA, et al. Among authors: manwani r. Transplantation. 2020 Feb;104(2):415-420. doi: 10.1097/TP.0000000000002813. Transplantation. 2020. PMID: 32004234
27 results